Understanding hormone replacement therapy risks and cancer

cancer.org

The FDA has removed a black box warning from some hormone replacement therapy products, indicating updated safety conclusions. This change reflects newer research and hormone types, but HRT risks still depend on individual health history and are detailed in patient information. Estrogen-only HRT still carries a black box warning for endometrial cancer risk, and HRT is not recommended for those with hormone-receptor-positive breast cancer.


With a significance score of 3, this news ranks in the top 13% of today's 29735 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Understanding hormone replacement therapy risks and cancer | News Minimalist